SQZ Biotech grabs $65m
Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has raised $65 million in Series D preferred stock financing.
Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has raised $65 million in Series D preferred stock financing.
Copyright PEI Media
Not for publication, email or dissemination